Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

CV Sciences Shares Outstanding 2011-2020 | CVSI

CV Sciences shares outstanding from 2011 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  
CV Sciences Annual Shares Outstanding
(Millions of Shares)
2019 98
2018 114
2017 80
2016 53
2015 35
2014 32
2013 10
2012 7
2011 7
2010 5
CV Sciences Quarterly Shares Outstanding
(Millions of Shares)
2020-09-30 100
2020-06-30 100
2020-03-31 100
2019-12-31 98
2019-09-30 99
2019-06-30 121
2019-03-31 95
2018-12-31 114
2018-09-30 116
2018-06-30 112
2018-03-31 96
2017-12-31 80
2017-09-30 88
2017-06-30 83
2017-03-31 60
2016-12-31 53
2016-09-30 52
2016-06-30 52
2016-03-31 50
2015-12-31 35
2015-09-30 35
2015-06-30 35
2015-03-31 34
2014-12-31 32
2014-09-30 33
2014-06-30 33
2014-03-31 26
2013-12-31 10
2013-09-30 10
2013-06-30 9
2013-03-31 8
2012-12-31 7
2012-09-30 7
2012-06-30 7
2012-03-31
2011-12-31 7
2011-09-30 7
2011-06-30 7
2011-03-31 7
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.074B $0.054B
CV Sciences Inc. is a life science company. Its operating segment consists of specialty pharmaceuticals and consumer products. Specialty pharma business segment is focused on developing and commercializing therapeutics utilizing synthetic Cannabidiol across several therapeutic areas. Consumer product business segment is focused on manufacturing, marketing and selling plant-based CBD products. It operates primarily in San Diego, California and Las Vegas, Nevada. CV Sciences Inc. is based in Las Vegas, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $74.625B 40.79
Takeda Pharmaceutical (TAK) Japan $54.353B 9.97
Astellas Pharma (ALPMY) Japan $29.938B 18.48
Eisai (ESALY) Japan $20.431B 22.66
Catalent (CTLT) United States $19.367B 51.25
Grifols, S.A (GRFS) Spain $11.111B 12.93
Neurocrine Biosciences (NBIX) United States $9.528B 22.10
Jazz Pharmaceuticals (JAZZ) Ireland $9.336B 15.59
Arrowhead Pharmaceuticals (ARWR) United States $8.369B 0.00
Ionis Pharmaceuticals (IONS) United States $7.790B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.754B 0.00
United Therapeutics (UTHR) United States $7.421B 14.41
IPSEN SA ADR (IPSEY) France $6.973B 0.00
Evotec AG (EVTCY) Germany $6.473B 437.14
Orion OYJ (ORINY) Finland $5.794B 20.11
Turning Point Therapeutics (TPTX) United States $5.633B 0.00
Sage Therapeutics (SAGE) United States $4.912B 0.00
ChemoCentryx (CCXI) United States $4.650B 0.00
Tilray (TLRY) Canada $4.449B 0.00
Nektar Therapeutics (NKTR) United States $4.325B 0.00
PTC Therapeutics (PTCT) United States $4.031B 0.00
Cronos Group (CRON) Canada $3.826B 0.00
FibroGen (FGEN) United States $3.486B 0.00
Hypermarcas (HYPMY) Brazil $3.458B 13.65
Pacira BioSciences (PCRX) United States $3.130B 52.86
Revolution Medicines (RVMD) United States $2.951B 0.00
Corcept Therapeutics (CORT) United States $2.907B 29.15
Taro Pharmaceutical Industries (TARO) Israel $2.755B 17.06
Xencor (XNCR) United States $2.668B 0.00
AlloVir (ALVR) United States $2.465B 0.00
Sundial Growers (SNDL) Canada $2.155B 0.00
USANA Health Sciences (USNA) United States $2.085B 16.91
BioCryst Pharmaceuticals (BCRX) United States $2.084B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.836B 0.00
ImmunoGen (IMGN) United States $1.812B 0.00
Organogenesis Holdings (ORGO) United States $1.725B 0.00
Endo (ENDP) Ireland $1.667B 2.52
Translate Bio (TBIO) United States $1.634B 0.00
Heron Therapeutics (HRTX) United States $1.616B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.534B 12.06
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.517B 9.73
Ocular Therapeutix (OCUL) United States $1.435B 0.00
Indivior (INVVY) United States $1.277B 0.00
Aclaris Therapeutics (ACRS) United States $1.204B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.183B 0.00
Zogenix (ZGNX) United States $1.137B 0.00
Trillium Therapeutics (TRIL) Canada $1.098B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.007B 0.00
Karyopharm Therapeutics (KPTI) United States $0.984B 0.00
Vectura Group (VEGPF) United Kingdom $0.952B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Aerie Pharmaceuticals (AERI) United States $0.929B 0.00
Radius Health (RDUS) United States $0.876B 0.00
VAXART, INC (VXRT) United States $0.841B 0.00
Collegium Pharmaceutical (COLL) United States $0.779B 29.49
Esperion Therapeutics (ESPR) United States $0.776B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.740B 0.00
Chinook Therapeutics (KDNY) United States $0.732B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.727B 0.00
Ardelyx (ARDX) United States $0.611B 0.00
Altimmune (ALT) United States $0.585B 0.00
Acutus Medical (AFIB) United States $0.584B 0.00
KalVista Pharmaceuticals (KALV) United States $0.580B 0.00
Jounce Therapeutics (JNCE) United States $0.580B 0.00
Molecular Templates (MTEM) United States $0.564B 0.00
Rafael Holdings (RFL) United States $0.556B 0.00
Flexion Therapeutics (FLXN) United States $0.546B 0.00
Akebia Therapeutics (AKBA) United States $0.542B 0.00
Summit Therapeutics (SMMT) United States $0.526B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.512B 0.00
Harpoon Therapeutics (HARP) United States $0.511B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.507B 0.00
Siga Technologies (SIGA) United States $0.507B 14.24
AVITA Medical (RCEL) United States $0.496B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.472B 0.00
DURECT (DRRX) United States $0.469B 0.00
PROFOUND MEDICL (PROF) Canada $0.456B 0.00
TherapeuticsMD (TXMD) United States $0.435B 0.00
MEI Pharma (MEIP) United States $0.416B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.410B 10.70
VYNE Therapeutics (VYNE) United States $0.374B 0.00
Innate Pharma SA (IPHYF) France $0.356B 0.00
Nature's Sunshine Products (NATR) United States $0.347B 22.35
Redhill Biopharma (RDHL) Israel $0.324B 0.00
Alpine Immune Sciences (ALPN) United States $0.316B 0.00
CASI Pharmaceuticals (CASI) United States $0.306B 0.00
Novan (NOVN) United States $0.267B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.255B 0.00
Lannett Co Inc (LCI) United States $0.252B 8.46
Xeris Pharmaceuticals (XERS) United States $0.250B 0.00
Oncternal Therapeutics (ONCT) United States $0.249B 0.00
Onconova Therapeutics (ONTX) United States $0.248B 0.00
Jaguar Animal Health (JAGX) United States $0.245B 0.00
CTI BioPharma (CTIC) United States $0.244B 0.00
IMV INC (IMV) Canada $0.225B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.217B 0.00
Concert Pharmaceuticals (CNCE) United States $0.212B 0.00
OptiNose (OPTN) United States $0.204B 0.00
Qilian Holding Group (QLI) China $0.203B 0.00
Calithera Biosciences (CALA) United States $0.203B 0.00
Iterum Therapeutics (ITRM) Ireland $0.200B 0.00
Taiwan Liposome (TLC) Taiwan $0.199B 0.00
IsoRay (ISR) United States $0.199B 0.00
Infinity Pharmaceuticals (INFI) United States $0.198B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.196B 0.00
Nutriband (NTRB) United States $0.194B 0.00
Heat Biologics (HTBX) United States $0.180B 0.00
KemPharm (KMPH) United States $0.178B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.173B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.171B 0.00
Aquestive Therapeutics (AQST) United States $0.167B 0.00
Champions Oncology (CSBR) United States $0.163B 0.00
Genocea Biosciences (GNCA) United States $0.161B 0.00
Aziyo Biologics (AZYO) United States $0.156B 0.00
GlycoMimetics (GLYC) United States $0.155B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.153B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.149B 0.00
Otonomy (OTIC) United States $0.140B 0.00
MediWound (MDWD) Israel $0.140B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.139B 0.00
Lipocine (LPCN) United States $0.127B 0.00
Assertio Holdings (ASRT) United States $0.121B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.120B 0.00
ProPhase Labs (PRPH) United States $0.119B 0.00
ElectroCore (ECOR) United States $0.115B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.105B 0.00
SCYNEXIS (SCYX) United States $0.098B 0.00
Natural Alternatives (NAII) United States $0.097B 26.19
AIM ImmunoTech (AIM) United States $0.095B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.095B 0.00
AgeX Therapeutics (AGE) United States $0.095B 0.00
Baudax Bio (BXRX) United States $0.095B 0.00
Recro Pharma (REPH) United States $0.089B 0.00
India Globalization Capital (IGC) United States $0.088B 0.00
PolarityTE (PTE) United States $0.088B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.084B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.083B 0.00
Addex Therapeutics (ADXN) Switzerland $0.077B 0.00
Biomerica (BMRA) United States $0.073B 0.00
Sigyn Therapeutics (SIGY) United States $0.069B 0.00
Brickell Biotech (BBI) United States $0.067B 0.00
Inhibikase Therapeutics (IKT) United States $0.067B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.060B 0.00
Plus Therapeutics (PSTV) United States $0.057B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.056B 0.00
Regulus Therapeutics (RGLS) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 26.15
RXi Pharmaceuticals (PHIO) United States $0.045B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.045B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.045B 0.00
Neos Therapeutics (NEOS) United States $0.042B 0.00
Mannatech (MTEX) United States $0.038B 5.65
China SXT Pharmaceuticals (SXTC) China $0.032B 0.00
Can-Fite Biopharma (CANF) Israel $0.031B 0.00
Midatech Pharma (MTP) United Kingdom $0.030B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.026B 0.00
Cyanotech (CYAN) United States $0.023B 19.10
Bellicum Pharmaceuticals (BLCM) United States $0.021B 0.00
JanOne (JAN) United States $0.020B 0.00
HANCOCK JAFFE (HJLI) United States $0.019B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Xenetic Biosciences (XBIO) United States $0.016B 0.00
SHINECO INC (TYHT) China $0.014B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00